News

Impressive Q2 2025 Financial Performance for AKVA Group

Impressive Q2 2025 Financial Performance for AKVA Group

High Activity and Solid Profitability

AKVA group has reported an impressive financial performance in Q2 2025, with quarterly revenue reaching an astounding MNOK 1,167, reflecting a remarkable 15% increase from the previous year's Q2 revenue of MNOK 1,014. This growth trajectory indicates a robust demand for the company's offerings and robust operational efficiency.

Revenue and Profit Growth

The company's EBITDA also saw a significant rise, climbing from MNOK 110 in Q2 2024 to MNOK 145 in Q2 2025, illustrating the enhanced profitability stemming from increased revenues and improved project margins, particularly in the Land Based segment. With total order intake reported at BNOK 1.1, a substantial rise from MNOK 888 in Q2 2024, the order backlog stood impressively at BNOK 2.7 by the end of June 2025.

New Contracts and Continued Growth

In May 2025, AKVA group entered into a new land-based contract with Laxey, valued at approximately MEUR 20. This contract demonstrates the company's ongoing commitment to expanding its service offerings and solidifying its position in the aquaculture industry. An additional land-based contract was awarded in mid-July, worth an estimated MEUR 8.5, further affirming AKVA’s growth momentum within this lucrative segment.

Segment Performance Review

Sea Based Segment

Focusing on the performance in the Sea Based (SB) segment, revenue for Q2 2025 reached MNOK 868, up from MNOK 842 in Q2 2024. The segment also experienced an upsurge in both EBITDA and EBIT, reaching MNOK 124 and MNOK 85, respectively, which translates to improved margins of 14.3% and 9.7%, compared to the prior year's 12.6% and 8.1%. Despite a slight dip in order intake, with Q2 2025 figures at MNOK 655 compared to MNOK 713 the previous year, the order backlog’s growth signifies ongoing demand for AKVA's sea-based solutions.

Land Based Segment

Revenue in the Land Based (LB) segment skyrocketed to MNOK 264, a substantial rise from MNOK 137 in Q2 2024. The EBITDA turned positive at MNOK 13, marking a significant turnaround compared to the preceding year's loss. The order intake has increased dramatically to MNOK 316, compared to MNOK 149 last year, and contributes to the impressive 60% share of total order backlog in this segment, amounting to MNOK 1,630.

Financial Health and Strategy

AKVA group maintains a stable financial structure, with working capital as a percentage of rolling revenue reported at 9.4%. By the end of Q2 2025, the company's cash reserves and unused credit facilities amounted to MNOK 473. Total assets and equity stood at MNOK 4,217 and MNOK 1,327 respectively, reflecting a solid equity ratio of 31.5%. The company boasts a leverage ratio of 2.30, adhering to all bank covenants, showcasing financial discipline.

Shareholder Value and Future Outlook

In line with its commitment to shareholder returns, AKVA group has declared a dividend of NOK 1 per share in the second half of 2025. The firm anticipates achieving a minimum revenue of BNOK 4.0 and an EBIT margin of 6% for the year, driven by continued advancements across its Sea Based, Land Based, and Digital divisions. The company aims for sustained growth momentum, particularly in innovative deep farming concepts.

About AKVA Group

AKVA group is a prominent technology and service provider for the global aquaculture industry, employing approximately 1,434 individuals and operating across 12 countries. With an impressive turnover of NOK 3.6 billion in 2024, it stands out as a leader in its field, providing comprehensive solutions that cover everything from standalone components to complete farming installations. Known for over 40 years as a pioneering technology provider, AKVA continues to shape the future of aquaculture.

Frequently Asked Questions

What financial performance did AKVA Group achieve in Q2 2025?

AKVA Group recorded quarterly revenue of MNOK 1,167, a 15% increase compared to Q2 2024, and noted EBITDA growth from MNOK 110 to MNOK 145.

What segments contributed to AKVA Group's performance?

The performance was driven by significant growth in both the Sea Based and Land Based segments, showcasing increased revenue and profitability.

What is the forecast for AKVA Group in 2025?

AKVA Group aims for a minimum revenue of BNOK 4.0 and an EBIT margin of 6% by focusing on innovative solutions across its business segments.

Did AKVA Group declare any dividends for shareholders?

Yes, the company has decided to pay a dividend of NOK 1 per share for the second half of 2025, enhancing shareholder returns.

What makes AKVA Group a leader in the aquaculture industry?

With over 40 years of experience, AKVA Group is recognized for its pioneering technology and comprehensive service offerings, marking it as a key player in the aquaculture sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 513

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Applied Materials: Navigating Earnings Signals and Market Trends

Updated Category News Views 180

Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...

Continue Reading
Transforming Money for the Digital Age with Lightspark

Updated Category News Views 363

Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...

Continue Reading
XploraDEX Token Launch Sets New Stage for DeFi Innovation

Updated Category News Views 184

Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...

Continue Reading
Empire Development Unveils Luxurious Real Estate Offerings

Updated Category News Views 253

Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...

Continue Reading
Biden's Final Moves: Key Actions Before Transitioning Power

Updated Category News Views 169

Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...

Continue Reading